(RCEL - AVITA MEDICAL INC)

company profile

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Avita Medical (RCEL) is trading at 4.67

Open Price
4.16
Previous close
4.67
Previous close
4.67
P/E Ratio
0
Sector
Health Care
Shares outstanding
30776689
Primary exchange
NASDAQ-NMS
ISIN
US05380C1027